clinical trial

AttributesValues
rdf:type
description
  • clinical trial (en)
  • ensayo clínico (es)
  • ensayu clínicu (ast)
  • klinisch onderzoek (nl)
  • клінічне випробування (uk)
  • تجربة سريرية (ar)
  • 临床试验 (zh)
rdfs:label
  • Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer (en)
skos:prefLabel
  • Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer (en)
name
  • Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer (en)
title
title
  • Randomized Phase 2 Clinical Trial of Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 in Patients With Recurrent Ovarian Cancer (en)
end time
end time
instance of
instance of
start time
start time
country
country
research site
research site
research intervention
research intervention
minimum age
minimum age
medical condition
medical condition
number of participants
number of participants
study type
study type
ClinicalTrials.gov ID
ClinicalTrials.gov ID
  • NCT05231122
clinical trial phase
clinical trial phase
research subject recruitment status
research subject recruitment status
is about of
Faceted Search & Find service v1.16.117 as of May 05 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software